Press Room | Heart Rhythm Society

Press Room

Welcome to the HRS 2020 Science Press Room. Here you will find all HRS-authored press releases as well as partner-authored press releases, which will be made available once their respective embargo lifts. The embargo for abstracts is Tuesday, May 5 at 5PM EDT. The embargo for Late-Breaking Clinical Trials is Friday, May 8 at 8AM EDT.

If you would like to register as press for HRS 2020 Science to gain access to all of the embargoed materials, including press releases presentations, and live/virtual press briefings, or to include your press release on this page, please contact

Press Room

Press Releases

HRS Press Releases
Industry Press Releases

Attribution Information

When referring to the online content in your press materials, please use "Heart Rhythm Society 2020 Science."

The Heart Rhythm Society should always be referred to as "Heart Rhythm Society" or "the Society". Please do not abbreviate the name as HRS.

When describing the Heart Rhythm Society in your press materials, please use the following text:

"The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients and is the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards. Incorporated in 1979 and based in Washington, D.C., it has a membership of more than 7,000 heart rhythm professionals in more than 70 countries around the world. For more information, visit"

Embargo Policy

Accepted abstracts are embargoed until 5:00 PM EDT on Tuesday, May 5, 2020. This means that information regarding any abstract submission may not be released before this time. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation.

Accepted Late-Breaking Clinical Trials abstracts are embargoed until 8:00 AM EDT Friday May 8, 2020. For more information, please contact

The Heart Rhythm Society reserves the right to alter embargo times at its discretion. All press materials on presentations and Late-Breaking Clinical Trials must have the abstract number as well as the date and time of the embargo prominently displayed at the top of the press release. Press releases may be issued in the months prior to Heart Rhythm 2020 Science, but the release must not in any way reveal the data or study results. If the study results are reported prior to the embargo date and time, the abstract is subject to removal from Heart Rhythm 2020 Science.

Late-Breaking Clinical Trials Press Briefing Attendance Policy

Only registered press are permitted to attend the scheduled live/virtual HRS 2020 Science press briefings with lead authors and moderators. All other individuals and/or parties who would like to gain access to the recordings of these press briefings (post-embargo), may send their request to for consideration beginning May 9, 2020 at 9AM ET. Each request will be reviewed on a case-by-case basis.